Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

Sangeeta Dhami; Ulugbek Nurmatov; Graham Roberts; Oliver Pfaar; Antonella Muraro; Ignacio J Ansotegui; Moises Calderon; Cemal Cingi; Pascal Demoly; Stephen Durham; Ronald Gerth van Wijk; Susanne Halken; Eckard Hamelmann; Peter Hellings; Lars Jacobsen; Edward Knol; Desiree Larenas Linnemann; Sandra Lin; Vivian Maggina; Hanneke Oude-Elberink; Giovanni Pajno; Ruby Panwankar; Elideanna Pastorello; Constantinos Pitsios; Giuseppina Rotiroti; Frans Timmermans; Olympia Tsilochristou; Eva-Maria Varga; Jamie Wilkinson; Andrew Williams; Margitta Worm; Luo Zhang; Aziz Sheikh

doi:10.1186/s13601-016-0099-6

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

Sangeeta Dhami, Ulugbek Nurmatov, Graham Roberts, Oliver Pfaar, Antonella Muraro, Ignacio J Ansotegui, Moises Calderon, Cemal Cingi, Pascal Demoly, Stephen Durham, Ronald Gerth van Wijk, Susanne Halken, Eckard Hamelmann, Peter Hellings, Lars Jacobsen, Edward Knol, Desiree Larenas Linnemann, Sandra Lin, Vivian Maggina, Hanneke Oude-ElberinkGiovanni Pajno, Ruby Panwankar, Elideanna Pastorello, Constantinos Pitsios, Giuseppina Rotiroti, Frans Timmermans, Olympia Tsilochristou, Eva-Maria Varga, Jamie Wilkinson, Andrew Williams, Margitta Worm, Luo Zhang, Aziz Sheikh

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Abstract

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.

METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.

CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

Original language	English
Article number	6:12
Number of pages	6
Journal	Clinical and Translational Allergy
Volume	6
DOIs	https://doi.org/10.1186/s13601-016-0099-6
Publication status	Published - 2016

Keywords

Allergy
Allergic rhinoconjunctivitis
Allergen immunotherapy
Rhinitis

Access to Document

10.1186/s13601-016-0099-6

3Final published version, 994 KB

Cite this

Dhami, S., Nurmatov, U., Roberts, G., Pfaar, O., Muraro, A., Ansotegui, I. J., Calderon, M., Cingi, C., Demoly, P., Durham, S., van Wijk, R. G., Halken, S., Hamelmann, E., Hellings, P., Jacobsen, L., Knol, E., Linnemann, D. L., Lin, S., Maggina, V., ... Sheikh, A. (2016). Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review. Clinical and Translational Allergy, 6, Article 6:12. https://doi.org/10.1186/s13601-016-0099-6

@article{a27a9b146f5d4ad98e2bad1408d43950,

title = "Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review",

abstract = "BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.",

keywords = "Allergy, Allergic rhinoconjunctivitis, Allergen immunotherapy, Rhinitis",

author = "Sangeeta Dhami and Ulugbek Nurmatov and Graham Roberts and Oliver Pfaar and Antonella Muraro and Ansotegui, {Ignacio J} and Moises Calderon and Cemal Cingi and Pascal Demoly and Stephen Durham and {van Wijk}, {Ronald Gerth} and Susanne Halken and Eckard Hamelmann and Peter Hellings and Lars Jacobsen and Edward Knol and Linnemann, {Desiree Larenas} and Sandra Lin and Vivian Maggina and Hanneke Oude-Elberink and Giovanni Pajno and Ruby Panwankar and Elideanna Pastorello and Constantinos Pitsios and Giuseppina Rotiroti and Frans Timmermans and Olympia Tsilochristou and Eva-Maria Varga and Jamie Wilkinson and Andrew Williams and Margitta Worm and Luo Zhang and Aziz Sheikh",

year = "2016",

doi = "10.1186/s13601-016-0099-6",

language = "English",

volume = "6",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "BioMed Central",

}

Dhami, S, Nurmatov, U, Roberts, G, Pfaar, O, Muraro, A, Ansotegui, IJ, Calderon, M, Cingi, C, Demoly, P, Durham, S, van Wijk, RG, Halken, S, Hamelmann, E, Hellings, P, Jacobsen, L, Knol, E, Linnemann, DL, Lin, S, Maggina, V, Oude-Elberink, H, Pajno, G, Panwankar, R, Pastorello, E, Pitsios, C, Rotiroti, G, Timmermans, F, Tsilochristou, O, Varga, E-M, Wilkinson, J, Williams, A, Worm, M, Zhang, L & Sheikh, A 2016, 'Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review', Clinical and Translational Allergy, vol. 6, 6:12. https://doi.org/10.1186/s13601-016-0099-6

TY - JOUR

T1 - Allergen immunotherapy for allergic rhinoconjunctivitis

T2 - protocol for a systematic review

AU - Dhami, Sangeeta

AU - Nurmatov, Ulugbek

AU - Roberts, Graham

AU - Pfaar, Oliver

AU - Muraro, Antonella

AU - Ansotegui, Ignacio J

AU - Calderon, Moises

AU - Cingi, Cemal

AU - Demoly, Pascal

AU - Durham, Stephen

AU - van Wijk, Ronald Gerth

AU - Halken, Susanne

AU - Hamelmann, Eckard

AU - Hellings, Peter

AU - Jacobsen, Lars

AU - Knol, Edward

AU - Linnemann, Desiree Larenas

AU - Lin, Sandra

AU - Maggina, Vivian

AU - Oude-Elberink, Hanneke

AU - Pajno, Giovanni

AU - Panwankar, Ruby

AU - Pastorello, Elideanna

AU - Pitsios, Constantinos

AU - Rotiroti, Giuseppina

AU - Timmermans, Frans

AU - Tsilochristou, Olympia

AU - Varga, Eva-Maria

AU - Wilkinson, Jamie

AU - Williams, Andrew

AU - Worm, Margitta

AU - Zhang, Luo

AU - Sheikh, Aziz

PY - 2016

Y1 - 2016

N2 - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

AB - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

KW - Allergy

KW - Allergic rhinoconjunctivitis

KW - Allergen immunotherapy

KW - Rhinitis

U2 - 10.1186/s13601-016-0099-6

DO - 10.1186/s13601-016-0099-6

M3 - Article

C2 - 27006751

SN - 2045-7022

VL - 6

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

M1 - 6:12

ER -

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review

Abstract

Keywords

Access to Document

Fingerprint

Cite this